A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer

被引:52
|
作者
Assenholt, Marianne S. [2 ]
Petersen, Jorgen B. [2 ]
Nielsen, Soren K. [2 ]
Lindegaard, Jacob C. [1 ]
Tanderup, Kari [1 ]
机构
[1] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Med Phys, DK-8000 Aarhus, Denmark
关键词
D O I
10.1080/02841860802266698
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. Locally advanced cervical cancer is usually treated with external beam radiotherapy followed by brachytherapy (BT). However, if response or tumour topography is unfavourable it may be difficult to reach a sufficient BT dose. The purpose of this study was to explore whether an applicator guided stereotactic IMRT boost could be combined with brachytherapy to improve dose volume parameters. Material and methods. Dose plans of 6 patients with HR CTV volumes of 31-100cc at the time of BT were analysed. MRI was performed with a combined intracavitary (IC)-interstitial (IS) ring applicator in situ. A radiotherapy schedule consisting of 45Gy (1.8Gy x 25) IMRT followed by boost of 28Gy (7Gy x 4fx) was modelled. Four different boost techniques were evaluated: IC-BT, IC/IS-BT, IC-BT+IMRT and IMRT. Dose plans were optimised for maximal tumour dose (D90) and coverage (V85Gy) while respecting DVH constraints in organs at risk: D2cc < 75Gy in rectum and sigmoid and < 90Gy in bladder (EQD2). In combined BT+IMRT dose plans, the IMRT plan was optimised on top of the BT dose distribution. Volumes irradiated to more than 60 Gy EQD2 (V60Gy) were evaluated. Results. Median dose coverage in IC plans was 74% [66-93%]. By using IC/IS or IC-BT+IMRT boost, the median coverage was improved to 95% [78-99%], and to 96% [69-99%] respectively. For IMRT alone, a median coverage of 98% [90-100%] was achieved, but V60Gy volumes were significantly increased by a median factor of 2.0 [1.4-2.3] as compared to IC/IS. It depended on the individual tumour topography whether IC/IS-BT or IC-BT+IMRT boost was the most favourable technique. Conclusion. It is technically possible to create dose plans that combine image guided BT and IMRT. In this study the dose coverage could be significantly increased by adding IS-BT or IMRT boost to the intracavitary dose. Using IMRT alone for boost cannot be advocated since this results in a significant increase of the volume irradiated to 60Gy.
引用
收藏
页码:1337 / 1343
页数:7
相关论文
共 50 条
  • [1] Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer
    Assenholt, Marianne S.
    Vestergaardl, Anne
    Kallehauge, Jesper F.
    Mohamed, Sandy
    Nielsen, Soren K.
    Petersen, Jorgen B.
    Fokdal, Lars
    Lindegaard, Jacob C.
    Tanderup, Kari
    BRACHYTHERAPY, 2014, 13 (04) : 361 - 368
  • [2] Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer
    Haack, Soren
    Nielsen, Soren Kynde
    Lindegaard, Jacob Christian
    Gelineck, John
    Tanderup, Kari
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 (02) : 187 - 193
  • [3] Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer
    Lindegaard, Jacob Christian
    Madsen, Mikkel Lnso
    Traberg, Anders
    Meisner, Bjarne
    Nielsen, Soren Kynde
    Tanderup, Kari
    Spejlborg, Harald
    Fokdal, Lars Ulrik
    Norrevang, Ole
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 (01) : 173 - 175
  • [4] VAGINAL MOULD APPLICATOR VERSUS OVOIDS: A 3D-MRI GUIDED BRACHYTHERAPY STUDY COMPARISON IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER.
    Mazeron, R.
    Dumas, I.
    Francois, G.
    Monnier, L.
    Vieillot, S.
    Haie-Meder, C.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S569 - S570
  • [5] Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer
    Bell, Lauren
    Holloway, Lois
    Bruheim, Kjersti
    Petric, Primoz
    Kirisits, Christian
    Tanderup, Kari
    Poetter, Richard
    Vinod, Shalini
    Lim, Karen
    Pogson, Elise
    Metcalfe, Peter
    Hellebust, Taran Paulsen
    BRACHYTHERAPY, 2020, 19 (02) : 146 - 153
  • [6] Impact of applicator reconstruction on the stability of DVH parameters in 3D image based brachytherapy in locally advanced cervical cancer
    Tanderup, K.
    Hellebust, T. P.
    Kirisits, C.
    Grau, C.
    Lindegaard, J. C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S95 - S95
  • [7] Applicator-guided SBRT boost combined with intracavitary brachytherapy for advanced cervical cancer
    Constantinescu, C.
    Jastaniyah, N.
    Ramahi, S. Wadi
    Nobah, A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S156 - S158
  • [8] MRI-guided brachytherapy and 3D/IMRT radiotherapy for cervical carcinoma. A prospective study
    Villafranca Iturre, E.
    Navarrete Solano, P.
    Sola Galarza, A.
    Muruzabal, J. C.
    Sanchez, C.
    Rico, M.
    Errasti, M.
    Barrado, M.
    Campo, M.
    Visus, I.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S934 - S935
  • [9] MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer
    Lindegaard, Jacob C.
    Tanderup, Kari
    Nielsen, Soren Kynde
    Haack, Soren
    Gelineck, John
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03): : 756 - 764
  • [10] 3D MRI-based evaluation of the 2D brachytherapy planning in patients with advanced cervical cancer: An analysis of the delivered dose
    Tomasevic, Aleksandar
    Karapandzic, Vesna Plesinac
    Rundic, Suzana Stojanovic
    Vuckovic, Sandra
    Milenkovic, Petar
    Gavrilovic, Dusica
    Marjanovic, Dragoslava
    Stanic, Dragana
    Mikovic, Mirjana
    Petrasinovic, Predrag
    JOURNAL OF BUON, 2020, 25 (01): : 108 - 115